Copyright
©The Author(s) 2024.
World J Clin Cases. Jun 16, 2024; 12(17): 3027-3034
Published online Jun 16, 2024. doi: 10.12998/wjcc.v12.i17.3027
Published online Jun 16, 2024. doi: 10.12998/wjcc.v12.i17.3027
Indicators | Control group (n = 75) | Research group (n = 85) | χ2/t value | P value |
Sex (male/female) | 45/30 | 49/36 | 0.091 | 0.763 |
Age (yr) | 56.97 ± 10.01 | 57.41 ± 9.02 | 0.292 | 0.770 |
Disease course (yr) | 6.04 ± 1.16 | 5.88 ± 1.44 | 0.767 | 0.444 |
NYHA cardiac function classification (II/III) | 34/41 | 40/45 | 0.048 | 0.827 |
Hypertension (with/without) | 38/37 | 36/49 | 1.108 | 0.293 |
DM (with/without) | 25/50 | 31/54 | 0.172 | 0.678 |
Hyperlipidemia (with/without) | 28/47 | 35/50 | 0.247 | 0.620 |
- Citation: Xu JJ, Dai J, Xie QH, Du PC, Li C, Zhou H. Effect of Luhong formula on the cardiac rehabilitation of patients with chronic heart failure. World J Clin Cases 2024; 12(17): 3027-3034
- URL: https://www.wjgnet.com/2307-8960/full/v12/i17/3027.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i17.3027